Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2019 | Prostate Cancer: radiation with or without androgen-deprivation

Nicolas Magne • 2 Jun 2019
ASCO 2019
Prostate Cancer Goserelin
GETUG-AFU

Nicolas Magne, MD, PhD, of the Lucien Neuwirth Oncology Institute, St-Priest-en-Jarez, France, tells us about the GETUG-AFU trial (NCT00423475), which investigated radiation therapy with or without goserelin in treating patients who have undergone surgery for recurrent or refractory prostate cancer. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

More from Nicolas Magne

Changing US prostate cancer practices
1:07
Changing US prostate cancer practices
Nicolas Magne • 2 Jun 2019
Radiotherapy: the need for further research
1:55
Radiotherapy: the need for further research
Nicolas Magne • 2 Jun 2019

Related Videos

Current and emerging systemic strategies in biochemically relapsed prostate cancer
2:45
Current and emerging systemic strategies in biochemically relapsed prostate cancer
Ashwin Sachdeva • 16 May 2026
Background and rationale for the PROTEUS trial in HR LPC/LAPC
0:48
Background and rationale for the PROTEUS trial in HR LPC/LAPC
Mary-Ellen Taplin • 29 May 2026
Future directions in prostate cancer from the PROTEUS trial
1:08
Future directions in prostate cancer from the PROTEUS trial
Mary-Ellen Taplin • 29 May 2026
Prognostic model for rPFS in mCRPC incorporating ctDNA with established risk factors
1:42
Prognostic model for rPFS in mCRPC incorporating ctDNA with established risk factors
Susan Halabi • 29 May 2026

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJOncology is intended for healthcare professionals